Exercise of over-allotment option and end of the stabilization period

Carnegie Investment Bank AB (publ) (“Carnegie”) and ABG Sundal Collier AB (“ABGSC”) exercise the over-allotment option regarding 2,043,966 shares in BONESUPPORT HOLDING AB (publ) (“BONESUPPORT” or the “Company”) and notifies that stabilization measures have been undertaken in the Company’s shares on Nasdaq Stockholm. The stabilization period has now ended and no further stabilization transaction will be effected.

As announced in connection with the offering to acquire newly issued shares in the Company and the listing of the Company’s shares on Nasdaq Stockholm (the ”Offering”), Carnegie and ABGSC may, acting as Joint Global Coordinators, carry out transactions aimed at supporting the market price of the shares at levels above those which might otherwise prevail in the open market.

Stabilization transactions may be undertaken on Nasdaq Stockholm, in the over-the-counter market or otherwise, at any time during the period starting on the date of commencement of trading in the shares on Nasdaq Stockholm and ending no later than 30 calendar days thereafter. Joint Global Coordinators are, however, not required to undertake any stabilization and there is no assurance that stabilization will be undertaken. Stabilization, if undertaken, may be discontinued at any time without prior notice. In no event will transactions be effected at levels above the price in the Offering.

The board of directors of the Company has granted Joint Global Coordinators an over-allotment option, which may be utilized in whole or in part for 30 days from the first date of trading in the Company’s shares on Nasdaq Stockholm, to issue up to 2,586,206 additional shares, corresponding to up to 15 percent of the total number of shares encompassed by the Offering, at a price corresponding to the price in the Offering, i.e. 29 SEK, to cover any over-allotment in connection with the Offering (the “Over-allotment option”). The Joint Global Coordinators now notify that the over-allotment option with respect to 2,043,966 shares has been exercised. The Company will thereby be provided with additionally approximately SEK 55 million, which means that the Company has been provided with approximately SEK 516 million as a result of the Offering, after issue expenses. Immediately following registration of the new shares issued pursuant to the Over-allotment option, the number of shares and votes in the Company will amount to 49,138,735. All shares in the Company that the Joint Global Coordinators have borrowed from Stiftelsen Industrifonden with the purpose of covering the over-allotment in the Offering will be returned within short. Following the exercise of the Over-allotment option, Stiftelsen Industrifonden and Lundbeckfond Invest A/S holds 4,787,806 shares in BONESUPPORT respectively, corresponding to approximately 9.7 percent respectively of the total shares outstanding in the Company. Due to the new share issue, Stiftelsen Industrifonden and Lundbeckfond Invest A/S have noted that their respective ownership will passively go below 10 percent.

Carnegie has, in its capacity as stabilization manager, notified that stabilization measures has been undertaken, in accordance with article 5(4) in the Market Abuse Regulation 596/2014, on Nasdaq Stockholm as specified below. The contact person at Carnegie is Anna Boqvist (tel: +46 8 588 688 00).

The stabilization period regarding the Offering has now ended and no further stabilization transactions will be effected. Specified below is a summary of the stabilization transactions which have been effected during the stabilization period in accordance with this press release and the press releases as of 5 July and 17 July 2017, respectively. All transactions during the stabilization period have been effected on Nasdaq Stockholm and no stabilization transactions have been effected on other dates than those specified below.

This information is information that BONESUPPORT HOLDING AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation 596/2014. The information was submitted for publication, through the agency of the contact person set out below, at 19:30 CET on 21 July 2017.